Status:

UNKNOWN

The Impact of the Use of the MAURISSE Application in People Suffering From an Addiction.

Lead Sponsor:

University Hospital, Toulouse

Conditions:

Substance Related Disorder

Personality Disorders

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Substance Use Disorders (SUD) are associated with cognitive schemas that lead to care attrition and mistrust towards care. Considering this, establishing a strong, trustful relationship between the pa...

Detailed Description

Substance Use Disorders (SUD) are frequently associated with other mental disorders, especially Borderline Personality Disorder, thus defining co-occurring substance use and mental disorders with bord...

Eligibility Criteria

Inclusion

  • Patient over 18 years old,
  • Starting specialized treatment for addiction (addiction to substance and behavioral addiction too as money games addiction).
  • Suffering from any type of addiction, with an active addiction requiring weekly monitoring of substance use.
  • possessing a smartphone or having access to a smartphone and having access to an internet connection.
  • Able to read and understand French.
  • Affiliated or beneficiary of a social security scheme.
  • Free, informed and written consent signed by the participant and the investigator (at the latest on the day of inclusion and before any examination required by the research).

Exclusion

  • Patient with cognitive or psychiatric disorders that may affect their ability to consent.
  • Participation in another protocol involving a modification of the treatment for addiction.
  • Known or suspected pregnancy.
  • Person under legal protection.

Key Trial Info

Start Date :

September 7 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 1 2025

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT05964296

Start Date

September 7 2023

End Date

March 1 2025

Last Update

September 13 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Hospital of Toulouse

Toulouse, France, 31059